Comeback Time for Liberty Health Sciences Inc (OTCMKTS: LHSIF) (CSE: LHS)

Liberty Health Sciences Inc (OTCMKTS: LHSIF) (CSE: LHS) is an exciting cannabis play that is starting to get noticed by investors. Currently trading near the bottom of its long term trading range the stock has a history of explosive moves up to much higher levels.

It’s easy to get excited about Liberty here; the Florida cannabis Company has the second highest sales of smokeable marijuana in the state and recently reported revenues for fiscal 2019 were a booming $50 million compared to $10 million for the year before. Liberty recorded net income for the fiscal year-end February 29, 2020 of $22.2 million. At current price levels a lot of Investors are starting to pick up on Liberty.

Liberty Health Sciences Inc (OTCMKTS: LHSIF) (CSE: LHS) is the cannabis provider committed to providing a high-quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale. Liberty’s product offerings include 11 outstanding quality brands including Liberty Health Sciences, Zentient, Pretty Pistil, Papa’s Herb, Mary’s Medicinals, PAX, GPen, Lemon and Grass, Clarity, DomPen, and Honey Vapes.

Liberty currently operates 25 dispensaries throughout Florida and has lease agreements in place for 10 additional locations and is negotiating for another ten locations. The Company received Florida Department of Health approval on its LHS360 Innovative Campus, which encompasses a grand total of 190,000 square feet of cultivation space, with an additional 50,000 square feet of processing and manufacturing space.

LHSIFMicrocapdaily first reported on Lieberty Health in September 2018 stating at the time:  Liberty boasts growing revenues recently reporting recent quarterly revenue totaled $2.2 million compared to $1.1 million for the previous quarter, a 95% increase. Liberty Health is a provider of trusted, high quality cannabis experiences and is quickly establishing itself as a major player in the Florida Cannabis market; the Company operates four dispensaries currently as well as six delivery hubs.

On June 26 Liberty announced record revenues for fiscal 2020 reporting Consolidated net sales for fiscal year-end February 29, 2020 were $50,075,579, compared with $10,002,538 for fiscal year-end February 28, 2019. The Company has made significant strides in maximizing efficiencies to achieve economies of scale and continues to grow in Florida while steadily expanding its dispensary footprint and product offerings.

Liberty CEO Victor Mancebo stated: “End of year fiscal 2020 proved to be the highest net revenue increase in the Company’s history and reflects our customer loyalty and strength of our brand. Liberty’s continued growth directly ties to the strategic initiatives we have set in place, which has been increasing our Florida production, retail base and delivery footprint along with expanding our product portfolio and brand partnerships. We continue to work on innovative strategies that complement our expansion plans while at the same time provide our patients a more accessible medicine platform.”

$LHS $LHSIF getting noticed on twitter:

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $125 million market valuation Liberty Health is an exciting cannabis play that is starting to get noticed by investors; Liberty operates 25 dispensaries throughout Florida and has lease agreements in place for 10 additional locations and is negotiating for another ten locations. The Company received Florida Department of Health approval on its LHS360 Innovative Campus, which encompasses a grand total of 190,000 square feet of cultivation space, with an additional 50,000 square feet of processing and manufacturing space. Liberty has the second highest sales of smokeable marijuana in the state of Florida and recently reported revenues for fiscal 2019 were a booming $50 million compared to $10 million for the year before. With a war chest of $25 million in the treasury, Liberty recorded net income for the fiscal year-end February 29, 2020 of $22.2 million. Currently trading near the bottom of its long term trading range the stock has a history of explosive moves up to much higher levels. Microcapdaily has reported on Liberty since September 2018. We will be updating on Liberty Health when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Liberty Health.

Disclosure: we hold no position in Liberty Health either long or short and we have not been compensated for this article.

Latest posts